Matrix Partners raises $750m

The China-focused arm of the US venture capital firm will continue to target technology and healthcare for its new fund.

Matrix Partners China has raised $750 million for its fifth venture capital fund, according to a filing with the U.S. Securities and Exchange Commission (SEC).

Having received commitments from 53 LPs, Matrix Partners China V will be invested in the technology and healthcare sectors in China.

The fund’s predecessor, Matrix Partners China IV, was closed on $500 million in 2016.